Skip to main content
Veterinary Medicines

Xylazine 2% 20 mg/ml šķīdums injekcijām liellopiem, zirgiem, aitām, suņiem, kaķiem

Authorised
This information is not available for this product.

Product identification

Medicine name:
Xylazine 2% 20 mg/ml šķīdums injekcijām liellopiem, zirgiem, aitām, suņiem, kaķiem
Active substance:
This information is not available for this product.
Target species:
  • Dog
  • Horse
  • Cat
  • Cattle
  • Sheep
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Horse
      • Not specified
        0
        day
  • Intramuscular use
    • Dog
    • Cat
    • Cattle
      • Not specified
        0
        day
    • Horse
      • Not specified
        0
        day
    • Sheep
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfasan International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan International B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/97/0544
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 18/03/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 18/03/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 18/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."